The government has zero budget set aside this year to procure updated doses of the COVID-19 vaccine to protect vulnerable ...
After that, the FDA approved the company’s updated COVID booster shot, making it available alongside shots from Moderna and Pfizer. The Sanofi deal was announced a few months after Novavax reported Q4 ...
The FDA is due to make its decision on ... The RSV vaccine could be a big moneymaker for Moderna. Pfizer and GSK launched their RSV shots for older adults last year. In the first quarter ...
Delaware State Police Troop 3 is issuing a Gold Alert for 11-year-old Isinay Ross of Magnolia, Delaware. Isinay was last seen on May 15, 2024, at her residence in Magnolia. […] The post State Police ...
Dr. Anthony Fauci knew COVID-19 vaccines were causing serious injuries within days of the vaccines’ rollout in December 2020, ...
In a change of pace from the recent COVID-related business struggles for Pfizer, the drugmaker has picked up a valuable reward from the FDA in the form of a priority review voucher (PRV).
The FDA’s full approval covers Tivdak in the treatment of recurrent or metastatic cervical cancer. Danish biotechnology company Genmab and Pfizer-owned Seagen codeveloped Tivdak under a cost ...
The US Food and Drug Administration (FDA) has approved Labcorp’s nAbCyte Anti-AAVRh74var HB-FE assay as a companion diagnostic to Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt). The assay ...
The findings reinforce advice recommending that those who received the J&J vaccine receive a second booster dose with an mRNA vaccine, the technology used in the Moderna and Pfizer shots ...
Pfizer (NYSE:PFE) and Danish drugmaker Genmab (GMAB) announced Monday that the U.S. FDA accepted a supplemental Biologics License Application granting full approval for their cervical cancer ...
Pfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug Administration (FDA) to treat patients with recurrent or metastatic cervical cancer with ...
The U.S. Food and Drug Administration (FDA) granted full approval for Pfizer's drug for treating cervical cancer patients whose disease had progressed on or after chemotherapy, the agency said on ...